ADBE: 16% | Adobe shares are trading higher following better-than-expected Q2 earnings and strong guidance.
BPTH: 46% | Bio-Path Holdings shares are trading higher after the company announced interim results from its Phase 2 study of prexigebersen in combination with decitabine and venetoclax for the treatment of acute myeloid leukemia.
MOLN: 14% | Molecular Partners shares are trading higher after the comapny announced preclinical proof-of-concept data from MP0621.